Insider Trading & Ownership - PARMAR KUSH

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for PARMAR KUSH
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-03-13
Purchase
2024-03-15
4:15 pm
Skye Bioscience Inc.SKYE5AM Partners VII LLC
5AM Ventures VII L.P.
5AM Partners II LLC
5AM Ventures II LP
5AM CO-INVESTORS II LP
DIEKMAN JOHN D
PARMAR KUSH
ROCKLAGE SCOTT M
10% Owner
450,000$10$4,500,00010,179,505
(Indirect)
View
2024-02-14
Sale
2024-02-16
4:15 pm
Enliven Therapeutics Inc.ELVN5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
PARMAR KUSH
Schwab Andrew J.
10% Owner
825,000$14.9$12,292,500635,341
(Indirect)
View
2024-01-31
Purchase
2024-02-02
4:32 pm
Skye Bioscience Inc.SKYE5AM Partners VII LLC
5AM Ventures VII L.P.
5AM Partners II LLC
5AM Ventures II LP
5AM CO-INVESTORS II LP
DIEKMAN JOHN D
PARMAR KUSH
ROCKLAGE SCOTT M
10% Owner
5,206,074$2.31$12,026,0319,729,505
(Indirect)
View
2024-01-31
Sale
2024-02-02
4:29 pm
Enliven Therapeutics Inc.ELVN5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
PARMAR KUSH
Schwab Andrew J.
10% Owner
500,000$15$7,500,000771,983
(Indirect)
View
2023-09-26
Sale
2023-09-28
4:27 pm
Enliven Therapeutics Inc.ELVN5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
PARMAR KUSH
Schwab Andrew J.
10% Owner
197,500$15$2,962,500854,796
(Indirect)
View
2023-08-24
Sale
2023-08-28
4:20 pm
Enliven Therapeutics Inc.ELVN5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
PARMAR KUSH
Schwab Andrew J.
10% Owner
440,000$16$7,040,000887,507
(Indirect)
View
2023-03-07
Sale
2023-03-09
4:39 pm
Rallybio CorpRLYBPARMAR KUSH
Director
100,000$8.2$820,0003,630,724
(Indirect)
View
2022-08-15
Purchase
2022-08-17
8:01 pm
CinCor Pharma Inc.CINC5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
Schwab Andrew J.
PARMAR KUSH
5AM Opportunities II (GP) LLC
5AM Opportunities II L.P.
10% Owner
600,000$30$18,000,000983,656
(Indirect)
View
2022-06-03
Sale
2022-06-07
5:03 pm
Rallybio CorpRLYBPARMAR KUSH
Director
10% Owner
150,000$12.5$1,875,0001,251,755
(Indirect)
View
2022-05-23
Sale
2022-05-25
6:34 pm
Rallybio CorpRLYBPARMAR KUSH
Director
10% Owner
100,000$13$1,300,0001,302,084
(Indirect)
View
2022-02-08
Sale
2022-02-10
6:22 pm
Rallybio CorpRLYBPARMAR KUSH
Director
210,000$13.05$2,740,5001,335,637
(Indirect)
View
2022-01-11
Purchase
2022-01-13
4:45 pm
CinCor Pharma Inc.CINC5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
Schwab Andrew J.
PARMAR KUSH
10% Owner
470,000$16$7,520,000496,323
(Indirect)
View
2021-11-16
Sale
2021-11-18
8:10 pm
Vor Biopharma Inc.VORPARMAR KUSH
Director
10% Owner
330,706$15.3$5,059,8021,766,634
(Indirect)
View
2021-11-02
Purchase
2021-11-05
08:49 am
Entrada Therapeutics Inc.TRDAPARMAR KUSH
Director
10% Owner
250,000$20$5,000,0001,132,357
(Indirect)
View
2021-11-01
Sale
2021-11-03
4:38 pm
Cabaletta Bio Inc.CABA5AM Ventures V L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
295,000$13$3,835,000333,144
(Indirect)
View
2021-09-07
Sale
2021-09-09
5:34 pm
Cabaletta Bio Inc.CABA5AM Ventures V L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
625,000$9.7$6,062,5002,359,263
(Indirect)
View
2021-08-02
Purchase
2021-08-04
9:19 pm
Rallybio CorpRLYBPARMAR KUSH
Director
615,384$13$7,999,9924,994,878
(Indirect
Direct)
View
2021-04-27
Purchase
2021-04-29
8:51 pm
IMPEL NEUROPHARMA INCIMPL5AM Ventures V L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
10% Owner
575,000$15$8,625,000575,000
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-01-02
Option Award
2024-01-04
5:58 pm
N/A
2034-01-02
Rallybio CorpRLYBPARMAR KUSH
Director
27,118$1.7727,118
(Direct)
View

Ownership
2023-08-28
4:18 pm
N/A
N/A
Skye Bioscience Inc.SKYE5AM Partners VII LLC
5AM Ventures VII L.P.
5AM Partners II LLC
5AM Ventures II LP
5AM CO-INVESTORS II LP
DIEKMAN JOHN D
PARMAR KUSH
ROCKLAGE SCOTT M
10% Owner
0$01,557,205,277
(Indirect)
View
2023-06-08
Option Award
2023-06-12
4:06 pm
N/A
2033-06-08
Entrada Therapeutics Inc.TRDAPARMAR KUSH
Director
10% Owner
16,000$016,000
(Direct)
View
2023-05-17
Option Award
2023-05-19
5:26 pm
N/A
2033-05-17
Rallybio CorpRLYBPARMAR KUSH
Director
15,490$015,490
(Direct)
View

Ownership
2023-03-06
5:18 pm
N/A
N/A
Enliven Therapeutics Inc.ELVN5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
PARMAR KUSH
10% Owner
0$05,798,475
(Indirect)
View
2023-02-24
Equity Swap
2023-02-28
4:29 pm
N/A
N/A
CinCor Pharma Inc.CINC5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities I L.P.
Schwab Andrew J.
PARMAR KUSH
5AM Opportunities II (GP) LLC
5AM Opportunities II L.P.
5AM Opportunities I (GP) LLC
10% Owner
4,937,646$00
(Indirect)
View
2023-01-03
Option Award
2023-01-05
6:29 pm
N/A
2033-01-03
Rallybio CorpRLYBPARMAR KUSH
Director
10,344$010,344
(Direct)
View
2022-11-30
Equity Swap
2022-12-02
4:49 pm
N/A
N/A
Akouos Inc.AKUSPARMAR KUSH
Director
10% Owner
4,135,786$00
(Indirect)
View
2022-12-01
Disposition
2022-12-02
4:49 pm
N/A
2032-06-22
Akouos Inc.AKUSPARMAR KUSH
Director
10% Owner
16,000$00
(Direct)
View
2022-06-23
Option Award
2022-06-27
5:02 pm
N/A
2032-06-22
Akouos Inc.AKUSPARMAR KUSH
Director
10% Owner
16,000$016,000
(Direct)
View
2022-06-15
Option Award
2022-06-17
4:05 pm
N/A
2032-06-15
Homology Medicines Inc.FIXXPARMAR KUSH
Director
18,000$018,000
(Direct)
View
2022-06-14
Option Award
2022-06-16
5:09 pm
N/A
2032-06-13
Vor Biopharma Inc.VORPARMAR KUSH
Director
10% Owner
16,911$016,911
(Direct)
View
2022-06-02
Option Award
2022-06-06
4:01 pm
N/A
2032-06-02
Entrada Therapeutics Inc.TRDAPARMAR KUSH
Director
10% Owner
11,918$011,918
(Direct)
View
2022-05-24
Option Award
2022-05-26
8:08 pm
N/A
2032-05-24
Rallybio CorpRLYBPARMAR KUSH
Director
13,440$013,440
(Direct)
View
2022-01-11
Conversion
2022-01-13
4:45 pm
N/A
N/A
CinCor Pharma Inc.CINC5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
Schwab Andrew J.
PARMAR KUSH
10% Owner
17,017,645$0496,323
(Indirect)
View

Ownership
2022-01-06
9:02 pm
N/A
N/A
CinCor Pharma Inc.CINC5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
Schwab Andrew J.
PARMAR KUSH
10% Owner
0$03,867,646
(Indirect)
View
2022-01-03
Option Award
2022-01-05
8:38 pm
N/A
2032-01-03
Rallybio CorpRLYBPARMAR KUSH
Director
5,772$05,772
(Direct)
View
2021-11-02
Conversion
2021-11-05
08:49 am
N/A
N/A
Entrada Therapeutics Inc.TRDAPARMAR KUSH
Director
10% Owner
3,827,224$01,132,357
(Indirect)
View

Ownership(A)
2021-11-05
08:48 am
N/A
N/A
Entrada Therapeutics Inc.TRDAPARMAR KUSH
Director
10% Owner
0$02,371,739
(Indirect)
View
2021-10-28
Option Award
2021-11-01
9:48 pm
N/A
2031-10-28
Entrada Therapeutics Inc.TRDAPARMAR KUSH
Director
10% Owner
23,552$023,552
(Direct)
View

Ownership
2021-10-28
9:57 pm
N/A
N/A
Entrada Therapeutics Inc.TRDAPARMAR KUSH
Director
10% Owner
0$04,158,379
(Indirect)
View
2021-07-28
Other
2021-08-04
9:19 pm
N/A
N/A
Rallybio CorpRLYBPARMAR KUSH
Director
26,341,690$04,994,878
(Indirect)
View
2021-07-28
Option Award
2021-08-04
9:19 pm
N/A
N/A
Rallybio CorpRLYBPARMAR KUSH
Director
13,440$04,994,878
(Direct)
View

Ownership
2021-07-29
7:38 pm
N/A
N/A
Rallybio CorpRLYBPARMAR KUSH
Director
10% Owner
0$03,588,780
(Indirect)
View
2021-06-24
Option Award
2021-06-25
4:38 pm
N/A
2031-06-23
Akouos Inc.AKUSPARMAR KUSH
Director
10% Owner
16,000$016,000
(Direct)
View
2021-06-17
Option Award
2021-06-22
5:40 pm
N/A
2031-06-17
Homology Medicines Inc.FIXXPARMAR KUSH
Director
18,000$018,000
(Direct)
View
2021-04-27
Conversion
2021-04-29
8:51 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPL5AM Ventures V L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
10% Owner
101,457$13.5575,000
(Indirect)
View
2021-04-27
Conversion
2021-04-29
8:51 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPL5AM Ventures V L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
10% Owner
39,725,924$0575,000
(Indirect)
View
2021-04-22
Other
2021-04-26
5:55 pm
N/A
2021-12-31
IMPEL NEUROPHARMA INCIMPL5AM Ventures V L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
1,359,799$01,359,799
(Indirect)
View
(A) Indicate amendment filing.
Goto 0, 1, Next